ArticleJournal of clinical medicine2025

The Importance of Comorbidities at Baseline and 5-Year Follow-Up in a Lung Cancer Biomarker Screening Trial.

Nimue Lilith Romeikat et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.